Streetbeat News

Analyst Ratings

ATGE

Adtalem Glb Education (NYSE:ATGE) has received 3 somewhat bullish and 1 indifferent analyst ratings in the last quarter. The company's average price target has increased by 6.52% from $46.00 to $49.00. The high and low price targets are $55.00 and $44.00 respectively.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 7:01 pm

CBRL

In the last quarter, 8 analysts have provided ratings for Cracker Barrel Old (NASDAQ:CBRL), with 1 bullish, 5 indifferent, and 2 bearish. The average 12-month price target for the company is $82.88, a decrease of 12.23% from the previous average of $94.43.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 7:00 pm

AVGO

Broadcom (NASDAQ:AVGO) has received 17 analyst ratings in the last quarter, with the majority being bullish or somewhat bullish. The average price target for the stock is $960.71, indicating an upside from the current price of $870.17. This average has increased by 7.77% from the previous average price target of $891.42.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 7:00 pm

GDRX

GoodRx Holdings (NASDAQ:GDRX) has received 15 analyst ratings in the last quarter, with 3 bullish, 1 somewhat bullish, and 11 indifferent. The average price target is $8.37, implying an upside from the current price of $6.285. The average price target has increased by 31.6% over the past month.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 7:00 pm

SGRY

Over the past 3 months, 5 analysts have published their opinion on Surgery Partners (NASDAQ:SGRY) stock. The analysts have an average price target of $48.8, implying an upside from the current price of $32.35. This current average represents a 6.15% decrease from the previous average price target of $52.00.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 7:00 pm

ALNY

An FDA advisory committee voted 9-3 in favor of Alnylam Pharmaceuticals' patisiran, but raised concerns about the drug's efficacy. The FDA has set an action date of October 8, 2023. Analysts from William Blair, Needham, Stifel, and Cantor Fitzgerald provided mixed views on the approval prospects and potential label restrictions. ALNY shares are down 8.08% at $194.55.

Portfolio Pulse from Vandana Singh

September 14, 2023 | 7:00 pm

SQ

A significant bearish stance has been taken on Block (NYSE:SQ) as evidenced by unusual options activity. The sentiment among big-money traders is split between 23% bullish and 76% bearish. Whales have been targeting a price range from $45.0 to $85.0 for Block over the last 3 months. The price of SQ is currently down -0.87% at $53.68. Several experts have downgraded their ratings on Block, with price targets ranging from $65 to $90.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 6:46 pm

NKE

A large investor has taken a bullish stance on Nike (NYSE:NKE), with 70% of big-money traders also showing bullish sentiment. The investor's position was noticed through publicly available options history. The investor's target price range for Nike over the last three months is between $80.0 and $110.0. Currently, Nike's price is up 1.27% at $97.35.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 6:31 pm

PG

A significant bullish stance on Procter & Gamble (NYSE:PG) has been observed, with unusual options activity. The sentiment among big-money traders is split between 58% bullish and 41% bearish. Whales have been targeting a price range from $130.0 to $165.0 for Procter & Gamble over the last 3 months. The price of PG is up 0.92% at $154.5, with RSI indicators suggesting the stock may be approaching overbought.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 6:31 pm

IBEX

RBC Capital Markets analyst Daniel R. Perlin has downgraded IBEX Limited (NASDAQ:IBEX) to Sector Perform from Outperform, lowering the price target to $18 from $27. This follows a disappointing Q4 for IBEX, with earnings missing estimates due to a challenging macro-environment. The analyst adjusted FY24 revenue and EBITDA estimates to $528 million and $68 million, respectively, lower than previous estimates. IBEX shares are trading lower by 25.10% to $13.60.

Portfolio Pulse from Nabaparna Bhattacharya

September 14, 2023 | 6:22 pm